63323-118-05 |
63323-118 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
Heparin Sodium |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20181116 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/.5mL |
24 BLISTER PACK in 1 CARTON (63323-118-05) / 1 SYRINGE in 1 BLISTER PACK (63323-118-01) / .5 mL in 1 SYRINGE |
63323-262-26 |
63323-262 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20200325 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-262-26) / 1 mL in 1 VIAL (63323-262-09) |
63323-262-55 |
63323-262 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20000319 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-262-55) / 1 mL in 1 VIAL |
63323-518-77 |
63323-518 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS |
20170824 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/100mL |
24 BAG in 1 CASE (63323-518-77) / 500 mL in 1 BAG (63323-518-01) |
81565-203-02 |
81565-203 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20220307 |
N/A |
NDA |
NDA017029 |
Phlow Corporation |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (81565-203-02) / 10 mL in 1 VIAL (81565-203-01) |
63323-540-13 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191104 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-13) / 1 mL in 1 VIAL (63323-540-03) |
63323-540-15 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191104 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-15) / 10 mL in 1 VIAL (63323-540-05) |
63323-540-36 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191104 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-36) / 30 mL in 1 VIAL (63323-540-33) |
63323-542-01 |
63323-542 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20000711 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
10000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-542-01) / 1 mL in 1 VIAL |
63323-262-06 |
63323-262 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20200325 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-262-06) / 1 mL in 1 VIAL (63323-262-03) |
63323-276-02 |
63323-276 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20000906 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-276-02) / 2 mL in 1 VIAL (63323-276-01) |
63323-522-77 |
63323-522 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS |
20170824 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/100mL |
24 BAG in 1 CASE (63323-522-77) / 500 mL in 1 BAG (63323-522-01) |
63323-459-14 |
63323-459 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191104 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
10000 [USP'U]/mL |
25 VIAL, MULTI-DOSE in 1 TRAY (63323-459-14) / 4 mL in 1 VIAL, MULTI-DOSE (63323-459-04) |
63323-540-01 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
19990927 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-01) / 1 mL in 1 VIAL |
63323-540-11 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
19990927 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-11) / 10 mL in 1 VIAL |
63323-540-31 |
63323-540 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
19990927 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
1000 [USP'U]/mL |
25 VIAL in 1 TRAY (63323-540-31) / 30 mL in 1 VIAL |
63323-543-13 |
63323-543 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191104 |
N/A |
NDA |
NDA017029 |
Fresenius Kabi USA, LLC |
HEPARIN SODIUM |
5000 [USP'U]/.5mL |
25 VIAL in 1 TRAY (63323-543-13) / .5 mL in 1 VIAL (63323-543-03) |
51662-1409-1 |
51662-1409 |
HUMAN PRESCRIPTION DRUG |
HEPARIN SODIUM |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20191111 |
N/A |
NDA |
NDA017029 |
HF Acquisition Co LLC, DBA HealthFirst |
HEPARIN SODIUM |
10000 [USP'U]/mL |
5 mL in 1 VIAL (51662-1409-1) |
51662-1409-3 |
51662-1409 |
HUMAN PRESCRIPTION DRUG |
HEPARIN SODIUM |
HEPARIN SODIUM |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20221110 |
N/A |
NDA |
NDA017029 |
HF Acquisition Co LLC, DBA HealthFirst |
HEPARIN SODIUM |
10000 [USP'U]/mL |
25 POUCH in 1 CASE (51662-1409-3) / 1 VIAL in 1 POUCH (51662-1409-2) / 5 mL in 1 VIAL |
0404-9979-01 |
0404-9979 |
HUMAN PRESCRIPTION DRUG |
Heparin Sodium |
heparin sodium |
INJECTION, SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20220117 |
N/A |
NDA |
NDA017029 |
Henry Schein, Inc. |
HEPARIN SODIUM |
1000 [USP'U]/mL |
1 VIAL, MULTI-DOSE in 1 BAG (0404-9979-01) / 1 mL in 1 VIAL, MULTI-DOSE |